Treat it or Leave it: Immuno-Oncology in Mesothelioma Observed by the Eyes of Argus

J Thorac Oncol. 2018 Nov;13(11):1619-1622. doi: 10.1016/j.jtho.2018.08.2024.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Humans
  • Immunotherapy
  • Lung Neoplasms*
  • Mesothelioma*

Substances

  • Antibodies, Monoclonal, Humanized
  • pembrolizumab